Loading...

Mind Cure Health Inc.

MCUR.CNCNQ
Healthcare
Biotechnology
CA$0.07
CA$0.00(0.00%)

Mind Cure Health Inc. MCUR.CN Peers

See (MCUR.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MCUR.CNCA$0.08N/A7M-0.75-CA$0.10N/A
BLU.TOCA$19.48-0.10%2.5B-20.29-CA$0.96N/A
MMED.NECA$14.90+9.48%1.1B-4.50-CA$3.31N/A
FRX.TOCA$10.66+2.01%294.4M-14.81-CA$0.72N/A
DRUG.CNCA$38.73-0.26%274.3M-193.65-CA$0.20N/A
CYBN.NECA$10.78+3.16%226.7M-2.17-CA$4.96N/A
EPRX.TOCA$5.84-1.35%209.4M-5.62-CA$1.04N/A
MSCL.TOCA$0.55N/A97M2.20CA$0.25N/A
ONC.TOCA$1.02+14.61%90.6M-2.49-CA$0.41N/A
MSET.CNCA$0.74-1.33%75M-12.33-CA$0.06N/A
Showing 1 to 10 of 59 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MCUR.CN vs BLU.TO Comparison

MCUR.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MCUR.CN stands at 7M. In comparison, BLU.TO has a market cap of 2.5B. Regarding current trading prices, MCUR.CN is priced at CA$0.08, while BLU.TO trades at CA$19.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MCUR.CN currently has a P/E ratio of -0.75, whereas BLU.TO's P/E ratio is -20.29. In terms of profitability, MCUR.CN's ROE is -1.61%, compared to BLU.TO's ROE of -0.22%. Regarding short-term risk, MCUR.CN is less volatile compared to BLU.TO. This indicates potentially lower risk in terms of short-term price fluctuations for MCUR.CN.

Stock Price Comparison

Loading...

Frequently Asked Questions